Van Thiel D H, Wright H I, Fagiuoli S, Gurakar A, Caraceni P
Department of Surgery, University of Pittsburgh, School of Medicine, PA 15213.
Indian J Gastroenterol. 1993 Dec;12 Suppl 3:22-4.
The preceding discussion has characterized the various types of viral hepatitis, both common and unusual, that can lead to subfulminant hepatic failure. Whenever specific medical therapy exists, it is preferred. If the disease has progressed sufficiently to prohibit survival inspite of medical therapy, OLT is indicated under the umbrella of continuing specific medical therapy. Conversely, if no medical therapy exists, OLT is the only possible therapy but should be used only if extrahepatic disease processes do not prohibit survival. Hopefully, with better and more effective means of immunosuppression, immunosuppression monitoring and the development of additional medical therapies for viruses, OLT will be used less often in cases of subfulminant viral hepatitis in the future.
上述讨论已对各种类型的病毒性肝炎进行了描述,包括常见的和不常见的,这些肝炎均可导致亚急性肝衰竭。只要有特定的药物治疗方法,就应优先选用。如果疾病进展到即便进行药物治疗也无法挽救生命的程度,则应在继续进行特定药物治疗的前提下,考虑进行肝移植(OLT)。相反,如果没有药物治疗方法,OLT是唯一可行的治疗手段,但仅在肝外疾病进程不影响生存的情况下才能使用。有望随着免疫抑制手段的改进和有效性提高、免疫抑制监测以及针对病毒的更多药物治疗方法的开发,未来在亚急性病毒性肝炎病例中,OLT的使用频率将会降低。